LMT

Lockheed Martin’s moat is built on long-duration U.S. and allied defense programs, high switching costs, and classified mission integration across air, missiles, space, and command-and-control. Customer demand remains strong, with total backlog around $194B as of late March 2026, supporting multi-year revenue visibility. Recent PAC-3 MSE integration work into Aegis reinforces its position in integrated air and missile defense as munitions and air-defense spending stay elevated.

Q1 2026 sales were about $18.0B with segment operating profit of $1.8B and EPS of $6.44, but profitability and cash generation were pressured versus Q1 2025 (net earnings $1.5B vs $1.7B). Trailing revenue is roughly $75.1B with trailing diluted EPS near $21.5, implying a mid-20s P/E at ~$510 if the stock is near recent levels, while ROE appears optically very high due to leverage and buybacks rather than pure operating strength. The dividend is about $13.80/share annually (~2.2% yield), and management reaffirmed 2026 free cash flow of $6.5–$6.8B, but near-term working-capital volatility is a key watch item.

Base case is a HOLD: backlog and reaffirmed 2026 guidance (sales $77.5–$80.0B; operating profit growth ~25%) can support a re-rating if execution improves, but Q1 margin/cash-flow strain raises confidence risk. Key 12-month catalysts are F-35 and missile/air-defense production ramp and delivery timing, while key risks include program adjustments (e.g., F-16 rework/delays) and funding or award timing shifts.

Recommendation: HOLD. Visibility from a ~$194B backlog and resilient shareholder returns support downside protection, but near-term execution/cash conversion uncertainty limits upside conviction at a mid-20s trailing earnings multiple.